Topic prioritisation
Showing 1 to 6 of 6
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Ferric citrate for managing iron and serum phosphorus levels in anaemia associated with chronic kidney disease [TSID12221] | None selected | Not selected | |
| Percutaneous nephrolithotomy for kidney stones greater than 1.5cm | None selected | Not selected | |
| Veverimer for treating metabolic acidosis in chronic kidney disease [ID3832] | None selected | Awaiting decision | |
| PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes, (MT740) | None selected | Not selected | |
| Bardoxolone methyl for treating chronic kidney disease in people 12 years and over with Alport syndrome [TSID9998] | None selected | Not selected | |
| RenalSense Clarity RMS for acute kidney injury MT601 (MIB256) | None selected | Not selected |